Why the study?
DAPT preloading prior to PCI is common practice, but clinical trial evidence demonstrating its benefit is lacking.
Does dual antiplatelet therapy (DAPT) before PCI improve clinical outcomes in patients with acute coronary syndrome?
Observational (n=42,453)
Yes
Does dual antiplatelet therapy (DAPT) before PCI improve clinical outcomes in patients with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
In a contemporary Australian registry, preloading with DAPT before PCI for ACS was common but not independently associated with improved clinical outcomes or reduced stent thrombosis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Batchelor et al. (2025) conducted an observational in Acute Coronary Syndrome (n=42,453). Dual Antiplatelet Therapy (DAPT) before PCI vs. Single or no antiplatelet therapy was evaluated on 30-day major adverse cardiovascular events (MACE) (p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: